COVIDIEN EXPOSES DR. DANIEL KRUSCHINSKI - GERMANY - OF PERFORMING EXPERIMENTAL SURGICAL PROCEDURES ON UNSUSPECTING HUMANS - MANY PATIENTS WERE FROM THE UNITED STATES!
COVIDIEN is an International provider of medical devices, supplies and pharmaceuticals.
Dr. Daniel Marian Kruschinski - a Polish surgeon was performing experimental operations in Germany on patients from the United States......has stated on numourouse occasions that his father was in Auschwitz concentration camp during WWII and he learned his methods from him! "These adhesion patients are sufferring no matter what I do to them, so I do operations on them to see what outcomes will be!" said Kruschiski!
Self proclaimed: Head of the Endoscopic Gynecology Centers in Germany. EndoGyn pursues the idea of Novel and progressive treatment modalities of gynecological endoscopy. 18 years experience and more than 5000 operations behind him and with the greatest experience worldwide and, at international level.
http://www.endogyn.de/index.php?seite=endogyn&sprache=en&a=EndoGyn&b=Physicians&c=DrKruschinski
Based on information found in the "Covidien" web site relating to the study of
"Spraygel Adhesion Barrier".........
(No abstract on this "study" is shown in the Covidien web site, as none exist!)
"Kruschinski et al. (2006) evaluated the efficacy of SprayGel™ in preventing adhesion reformation during adhesiolysis procedures in patients with adhesion related disorder.
Following gas less laparoscopic adhesiolysis, 35 patients received SprayGel™ application, followed by a second-look laparoscopy at Day 7 and, in cases of continued pain, a third-look laparoscopy within 6 months after the initial surgery".........more:
Learn More About the SprayShield™Adhesion Barrier:
http://www.or-live.com/covidien/2457/index.cfmcmpid=SprayShieldPostcard
Bottom Right On This Page
Pre-Clinical Data
Page 4
Discussion
http://www.or-live.com/covidien/2457/Pre-clinical%20Data.pdf
********************************************
ALL of the patients from the United States were unsuspecting "human experiments" and were charged for their surgeries, paying Dr. Kruschinski thousands of US dollars.
A number of these patients returned for multiple operations by Dr. Kruschinski, and again paid thousands of dollars for what is now recognized as unauthorized medical experiments.
* Patients from the United States listed below in this post!
Not only did Dr. Kruschinski perform these operations without the knowledge of the German Medical Board, he violated the German Laws & Ethics governing "clinical trials" in that country, which parallels the "Ethics and Laws" of clinical studies in the USA! * See reports below in this post!
Kruschinski never related to his patients that his "Adhesiolysis procedures with Spraygel" was of an "experimental basis!"
Information in the "Covidein" web site also exposed that Dr. Kruschinski misrepresented the surgical results of his "gas less adhesiolysis procedure" to his patients, and the world by use of his Endogyn web site...........
Dr. Kruschnsi made claims that no re-formed or Denovo adhesion formation was found at second look procedures! He claimed over and over that patients undergoing his "gas less adhesiolysis procedure" were 100% adhesion free at SLL, he even validated those claims by posting pictures of the SLL results of these patients!"
(Never did Dr. Kruschinski offer to do video taping of his surgical procedures, though he claimed he had "state of the art" surgical equipment in his operating room! Desperate vulnerable adhesion patients from the USA bought that lie without question, and more then once for some of them!)
http://www.endogyn.de/index.php?seite=endogyn&sprache=en&a=Specialtreatments&b=Adhesions
Per the Covidien web site, Dr. Kruschinski makes the following claims...
(Again, no abstracts associated with these claims is avaiable, anywhere!)
"The reduction in the adhesion score at Day 7 was 89.8% (90.1% reduction in extent,
89.3% reduction in severity, and 89.9% reduction in grade).
Five patients (14.3%) had a third-look laparoscopy within 6months of the initial surgery, in which four cases of adhesion reformation were confirmed."
***************************************************
If YOU had an "Adhesiolysis with Spraygel" in Germany under the scalpel of Dr. Daniel Kruschinski, you were a human experiment, and if you are currently presenting with abdominal/pelvic pain, it is more then probable that your pain and suffering is from adhesions!
(Patients undergoing adhesiolysis in Germany with Kruschinski have been given every excuse in the book for recurring pain following his procedure, and many are once again buying his lies!)
Contacts for the "Germany Agencies" governing clinical trials in Germany, and "Government Agencies" currently involved with investigations of Dr. Daniel M. Kruschinski will be Posted Soon on IHRT!
Contact these agencies to report you experience with Dr. Kruschinski and to seek monetary compensation! YES! It is possible to recoup your money through the German courts by submitting your claim against Daniel Kruschinski's bankruptcy (insolvency) actions!!)
*See "Bankruptcy Report" on Dr. Kruschinski at this link....
http://eedogynde.blogspot.com/2009/02/too-al-vitim-of-dr-daniel-kruschinski.html
IHRT encourages all patients to Dr. Kruschinski to also contact "Covidien" and request the "Abstracts" from the "Endogyn SprayGel Adhesiolysis" clinical studies performed by Dr. Daniel Kruschinski as represented in the Covidien web site!
* See contacts below in this post!
(Keep in mind that the following clinical study, also found in the Covidein web site, was deemed invalid due to Mettler frauding a "mirror" report of this same study where she inflated numbers on her fraudulant report and attempted to submit that for fact! Mettler got caught, but at the same time, she rendered this real Abstract useless!! Shameful indeed Mettler! )
Mettler L, Audebert A, Lehmann-Willenbrock E, Schive-Peterhansl
K, Jacobs VR. A randomized, prospective, controlled,
multicenter clinical trial of a sprayable, site-specific adhesion
barrier system in patients undergoing myomectomy. Fertil
Steril. 2004 Aug;82(2):398-404.
IMPORTANT NOTICE ABOUT COVIDIEN and the SPRAYSHIELD.........
It appears that Covidien is currently involved in a similar scam with Dr. Kruschinski as he makes claims in his web site that he is currently doing the clinical trials for Covidien and the SprayShield, though there is no record of these clinical trials being authorized by the German Government for Kruschinski to be involved in them.
Once again we see that Kruschinski is using unethical and "novel" means of sharing the "Covidien SprayShield" clinical trials results by using his web site "message board!"
It is all to apparent to IHRT that Daniel Kruschinski is once again perpetrating crimes against humanity as he performs "experimental" operations with the "Covidien SprayShield Adhesion Barrier" on unsuspecting vulnerable patients once again! Covidien appears to be sanctioning these studies by not denying their association with Endogyn and Dr. Daniel Kruschinski when contacted by IHRT representatives.
Endogyn aka Covidien.....
http://www.endogynserver.com/cgi-bin/210/cutecast.pl?session=JLfQfTdhRrPldW6vOIJSnuet0s&forum=2&thread=20815
http://www.endogynserver.com/cgi-bin/210/cutecast.pl?session=JLfQfTdhRrPldW6vOIJSnuet0s&forum=2&thread=20820
(A bit of gossip, but we all know that with any gossip, there is a bit of truth!: It has been brought to IHRT's attention that "Covidien" has a reputation of being rather "unscrupulous" and not above dealing in unethical and "novel" means to get the end means of their product on the world wide market!)
Vice President Investor Relations - Covidien
> Eric Kraus
http://www.covidien.com/
Contacts Eric Kraus
Coleman Lannum, CFA
Senior Vice President
Corporate Communications
Vice President Investor Relations
Tele: 508-261-8305 or 508-452-4343
Email: eric.kraus@covidien.com
Clinical Trials: The Growing Business Of Medical Experimentations ...
Differences between clinical trials according to the German law on pharmaceuticals (Arzneimittelgesetz) and trials according to the German law on medical products (Medizinproduktegesetz)]
Krummenauer F.
Institut für Medizinische Biometrie, Epidemiologie und Informatik der Universität Mainz. krummi@imsd.uni-mainz.de
PURPOSE: Similar to the registration process for pharmaceutical agents, medical devices have to undergo standardized clinical evaluation before being marketed and used in routine therapy or diagnostics. However, conduction, submission, and reporting of such clinical evaluations to authorities has to follow the German law on medical products(Medizinproduktegesetz,MPG), which in some central aspects differs remarkably from the German law on pharmaceuticals (Arzneimittelgesetz,AMG).
METHODS: Relevant deviations of MPG requirements from those of the AMG are reviewed with particular emphasis on submission, conduction, and reporting of trials to the authorities in charge.
RESULTS: Whereas AMG-based trials focus on the proof of efficacy of pharmaceutical agents, the MPG demands instead proof of functionality of the medical devices; the MPG therefore concentrates more on technically satisfactory results in the context of function and patient safety. The aim of MPG trials is thus CE marking instead of AMG-based registration. However, this focus on functionality implies that medical devices need not necessarily be tested in a clinical trial--in some settings evidence-based evaluation alone will be sufficient. The decision on the necessity of a clinical trial is based mainly on the risk profile and invasive character of the device at hand.
CONCLUSIONS: The early consideration of differences between AMG and MPG concerning the role and conduction of clinical trials will remarkably increase the (CE) certification process's outcome quality and juridical validity.Publication Types:
· Comparative Study
· English Abstract
*****************************************************
Responsibilities of ethics committees]
Med Klin (Munich). 2000 May;95(1 Spec No):15-7.
von Bergmann K.
Abteilung für Klinische Pharmakologie der Medizinischen Fakultät, Rheinische Friedrich-Wilhelms-Universität Bonn.
Increasing numbers of clinical research projects are submitted to ethical committees (institutional review boards) for approval. New therapeutic developments have to be evaluated by these committees to protect patients/volunteers. Thus, the responsibility of ethical committees is increasing.
The "Nürnberger Kodex" and the "Declaration of Helsinki" are the background for these evaluations. According to the German drug law the physician is obligated by law to submit the protocol to such a committee. In addition, local state physician authorities require such a procedure.
Important considerations during the review process besides ethical aspects are the informed consent, which should be written in an understandable form, and the obligations of the insurance.
PMID: 10851843 [PubMed - indexed for MEDLINE]
· [Responsibilities of ethics committees] [Med Klin (Munich). 1999]
· [Recording and reporting adverse reactions in clinical trials. New legal provisions according to the 12th Law Amending the German Drug Law (AMG) and the Ordinance on GCP (GCP-V)] [Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2005]
· [Therapeutic trial, clinical research and therapeutic freedom--legal boundaries] [Z Arztl Fortbild Qualitatssich. 1997]
· ReviewEthics committees and achievement of good clinical practice. [Therapie. 1996]
· ReviewEthical considerations. [Epilepsy Res Suppl. 1993]
****************************************************
National Institiute of Health - USA
http://www.ncbi.nlm.nih.gov/pubmed/6677881?dopt=
Abstract
Comparison of German and American law concerning clinical trials.
Deutsch E.
In German and American law, clinical trials require a positive benefit-risk evaluation, free and informed consent, medical and scientific qualification of the doctor, and a written research protocol. American law requires a written consent, which is free of undue influence, the subject being instructed that he is free to withdraw from the trial.
In German law, an orally given consent is sufficient for therapeutic trials. With minor or incompetent research subjects, informed consent to therapeutic clinical experimentation has to be given by their parents or guardians, the permissibility of which, in other trials, is controversial.
In non-therapeutic trials, blind studies, double-bind studies, and trials involving placebos, special attention has to be paid to the risk-benefit analysis and to informed consent, which in these cases, even in Germany, must be written.
The most outstanding feature of American law of clinical trial is that the experimentation is subject to previous control and approval by institutional review boards.
The most interesting difference in German law is the investigator's duty to effect an insurance against the risks of the research subject's death or invalidity.
****************************************************
http://www.clinicaltrialssearch.org/germany_clinical_trials.html
Germany Clinical Trials
Information presented on Clinical Trials Search isn't designed to be a substitute for proven medical advice, travels to or treatment with a real mD.
We are not doctors. Always consult your local Germany physician on conditions.
Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Germany Clinical research trials and Germany health trials occur in hundreds of Germany localities. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectiveness of new does drugs. The purpose of the studies / undertakings is to figure out particular human medical questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate remedies for all kinds of conditions.
Germany Clinical Trials and other clinical trials permit volunteers to access medical treatment options before they are available to the masses.
Most times the human subjects receive treatment for without cost, and every now and again they are compensated for their time.
Test subjects oftentimes obtain the best healthcare available for their condition. Risks are a reality, nonetheless, and can include extra or frequent physician calls, health hazards (potentially life-threatening), and/or the treatment being ineffective.
Trials are federally regulated with rigorous guidelines to protect clinical trials patients.
*****************************************************
EndoGyn® Ltd.
Endoscopic Gynecology Centers Ltd.
Registered at Companies House for England and Wales
Company No. 5914561
Regional office: Wolfenbütteler Str. 41 D-38124 Braunschweig
Registered at district court Braunschweig HRB-Nr. 201524
Info - Phone: +49 180 /
ENDOGYN (3636496)
Fax: +49 7000 /
eMail: Info@EndoGyn.com
http://www.adhesions.de/index.php?seite=verw&sprache=en&x=Imprint
***************************************
USA Patients contacts Endogyn
http://www.endogyn.de/index.php?seite=endogyn&sprache=en&a=Patients-Info&b=Patientscontacts&c=International
(This list is in part as many patients to Endogyn refused to have thier names made public. All the patients listed here gave permission for their contact information to be accessed via the Internet.
IHRT does have the most conprehgensive list of patient who went to Europe for adhesiolysis procedures with SprayGel, as well as patients in the USA! )
Name ** eMail ** Telephone ** Location ** Which operation? ** Mulptiple trips to Endogyn for Surgery
Bauman, Dan
thesticher@defnet.com
+1 (419) 782-3944
Ohio
Adhesiolysis via gasless laparoscopy with SprayGel, AdhesionsDate: 01.11.2003
****
Bolt, Frank
fcbolt@comcast.net
+1(856) 232-0653
Turnersville
Adhesiolysis via gasless laparoscopy with SprayGel, AdhesionsDate: 11.02.2005
****
Bosso, Candy
candyajb@yahoo.com
+1 (847) 918 - 1470
Mundelein
Adhesiolysis via gasless laparoscopy with SprayGel, AdhesionsDate: 11.03.2005
****
Cheryl Dixon
herbcheryl1@msn.com
+1 (503) 316-0575
Salem, Oregon
Adhesiolysis via gasless laparoscopy with SprayGel, AdhesionsDate: 22.04.2005
****
Creacy, Lynn
mailto:lynn.creacy5@verizon.net%20
+1 972 394 9061
Adhesiolysis via gasless laparoscopy with SprayGel, AdhesionsDate: 23.01.2004
****
Dawson Kay Belinda
bailey-teresa@hotmail.com
+1 (409) 579-4000
jasper, Texas
Adhesiolysis via gasless lift-laparoscopy with SprayGel, AdhesionsDate: 13.08.2007
****
** Dynda Helen - Multiple trips
hdynda77@runestone.net
+1 (320) 986-2898
Hofman
Adhesiolysis via gasless laparoscopy with SprayGelDate: 18.07.2003
****
Falor, Barbara
bfalor@hughes.net
+1 (419) 822 9283
Ohio
Adhesiolysis via gasless laparoscopy with SprayGel, AdhesionsDate: 03.12.2004
****
Fitzgeral Barbara
carnival@foodbooth.net
+1 (503) &"(-"=)=
Cornelius, Oregon
Adhesiolysis via gasless Lift-Laparoscopy with SprayGel AdhesionsDate: 21.02.2007
****
Foster, Terry and Kevin
KF106@aol.com
Adhesiolysis via gasless laparoscopy with SprayGel, AdhesionsDate: 07.02.2003
Froelich, Barb and Leon
the_sticher@webtv.net
(419) 658-4022
****
Gasless laparoscopic adhesiolysis Date: 07.11.2003
Fuller, Barbara (Mother of an ARD sufferer)
barbiejo44@sbcglobal.net
+1 (209) 368-5536
Hughson
Adhesiolysis via gasless laparosocpyDate: 04.05.2005
****
Gibbs Effie
effiegibbs@hotmail.com
+1 (580) 263 0270
Adhesiolysis via gasless laparoscopy with SprayGel, AdhesionsDate: 27.02.2006
****
** Graven, Lisa - Multple trips
lilylover5555@aol.com
+1 (419) 893 5645 (home)+1 (419) 346 7547 (cell phone)
Ohio
Adhesiolysis via gasless laparoscopy with SprayGel, AdhesionsDate: 19.07.2002
****
** Grigg, Sally Multiple trips
howardcreekranch@mcn.org
+1 (707) 964-6725
California
Adhesiolysis via gasless laparoscopy with SprayGel, AdhesionsDate: 25.10.2002
****
Haber, Connie
spincon58@hotmail.com
+1 (732) 870-8775+1 (732) 996-3900
New Jersey
Adhesiolysis via gasless laparoscopy with SprayGel, AdhesionsDate: 08.08.2003
****
Hawkins-Bauman, Mic
thesticher@defnet.com
(419) 782-3944(508) 580-1592
Ohio
Gasless laparoscopic hysterectomyDate: 07.11.2003
****
Heimburg, Deborah
debbie@cmg.net
+1 (908) 236-9859
New Jersey
Adhesiolysis via gasless laparoscopy with SprayGel, AdhesionsDate: 06.06.2003
****
Hiltz-Scerbo, Leiza Ann
leizahiltz@yahoo.com
+1 (207) 778 2331
Famington
Adhesiolysis via gasless laparoscopy with SprayGel, AdhesionsDate: 11.02.2005
****
Jauernig Shiela
rsmj333@sbcglobal.net
+1 (979) 733-8041
Columbus Texas
Adhesiolysis via gasless laparoscopy with SprayGel, AdhesionsDate: 03.06.2005
****
Kessler, Claudia and Rick
claudykessler@yahoo.com
Adhesiolysis via gasless laparoscopy with SprayGel, AdhesionsDate: 29.07.2003
****
Kirk, Dusti
Dusti.Kirk@oscn.net
+1 (580) 497-2610
Cheyenne, OK
Adhesiolysis via gasless laparoscopy with SprayGel, AdhesionsDate: 14.01.2005
****
Knouse Danita
danita.longo@yahoo.com
+1 (814) 371-5821
Dubois, PA 15801
Adhesiolysis via gasless laparoscopy with SprayGel, AdhesionsDate: 07.09.2006
****
Lozich Kathy
mlozich@aol.com
+1 (972) 542 1117
Gasless laparoscopic adhesiolysisDate: 22.04.2005
****
Lyn Joyce and Raymond
rl08184@yahoo.com
+1 (863) 852-3625
New York
Adhesiolysis via gasless laparoscopy with SprayGel, AdhesionsDate: 28.01.2005
****
Marshall, Liz
lizm6812@aol.com
+1 (253) 630-2088
Adhesiolysis via gasless laparoscopy with SprayGel, AdhesionsDate: 06.06.2003
****
Mizrachi Yeali
skybluepink@adelphia.net
+1 (207) 433-5819
Bangor, Maine
Adhesiolysis via gasless laparoscopy with SprayGel, AdhesionsDate: 06.12.2006
****
Porzuczek Marzena
marzena.p@comcast.net
+1 (815) 230 5253
Plainfield, IL
Adhesiolysis via gasless laparoscopy with SprayGel, AdhesionsDate: 05.07.2006
****
Purcel Jaimie and Joe
purcell38@hotmail.com
+1 (520) 876-4205
Casa Grande, AZ 85222
Adhesioloyis via gasless laparoscopyDate: 08.04.2005
****
Rahlf Jennifer
3rahlfs@verizon.net
+1 (951) 694-5219
Adhesiolysis via gasless laparoscopy with SprayGel, AdhesionsDate: 17.06.2005
****
Reed, Rebecca
oopsreed@aol.com
+1 (817) 423-1170
Adhesiolysis via gasless laparoscopy with SprayGel, AdhesionsDate: 23.04.2004
****
Reed-McWilliams, Karen
Karen_McWilliams@allenisd.org
+1 (972) 442-7730
Adhesiolysis via gasless laparoscopy with SprayGel, AdhesionsDate: 06.10.2003
****
Sampson Sandra
ssandym3@charter.net
+1 (918) 448-4088
Boston, MA
Adhesiolysis via gasless Lift-Laparoscopy with SprayGel AdhesionsDate: 17.01.2007
****
Scala-Paladino, Carmela
mela14@optonline.net
+1 (732) 851-5643
732-851-5643
Adhesiolysis via gasless laparoscopy with SprayGel, AdhesionsDate: 02.07.2004
****
Schierloh Maureen
miata1121@cfl.rr.com
+1 (407) 443-2897
Adhesiolysis via gasless laparoscopy with SprayGel, AdhesionsDate: 13.01.2006
****
Sheaks, Jill
jillsheaks@yahoo.com
+1 (419) 596-3345
Adhesiolysis via gasless laparoscopy with SprayGel, AdhesionsDate: 26.03.2004
****
Simpson, Janice
Sybylsmom@msn.com
+1 (508) 580-1592
Adhesiolysis via gasless laparoscopy with SprayGel, AdhesionsDate: 05.03.2004
****
Sowers Lyn Dell
lyndell_sowers@hotmail.com
+1 (717) 343-0131
Adhesiolysis via gasless laparoscopy with SprayGel, AdhesionsDate: 02.12.2005
****
Steward Melissa
melissasgb@yahoo.com
Texas
Adhesiolysis via gasless laparoscopy with SprayGel, AdhesionsDate: 10.04.2003
****
Steward, Karen (Mother of Melissa)
kann@charter.net
http://www.karensteward.typepad.com/
Texas
Gasless laparoscopic adhesiolysis
****
Thompson Bonnie
Keithinsrh@aol.com
+1 (732) 774 1158
Neptune
Adhesiolysis via gasless laparoscopy with SprayGelDate: 02.12.2005
****
STAY TUNED FOR THE LINKS TO GERMAN AGENCIES WHERE YOU CAN SEEK FACTUAL INFORMATION ABOUT THE CURRENT STATE OF AFFAIRS (FIASCOS)
OF
- DR. DANIEL M. KRUSCHINSKI -
No comments:
Post a Comment